HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philosophy

This article was originally published in The Rose Sheet

Executive Summary

Upcoming expansion in markets outside U.S. expected to generate 50% sales gain in 2002, co-founder David Watson says. Currently available in 100 U.S. department and specialty store doors, brand generates annual sales of approximately $30 mil., according to exec. Philosophy skin care, hair care and fragrances are sold in retailers such as Sephora, Nordstrom and Saks, as well as home shopping channel QVC. Phoenix, Ariz.-based Philosophy is sister company of BioMedic skin care business for physicians, which is being sold to L'Oreal by Watson and co-owner Cristina Carlino (1see story, p. 6)

You may also be interested in...



L'Oreal BioMedic Purchase To Expand Skin Care Sales Through MDs

The acquisition of Phoenix, Ariz.-based BioMedic by L'Oreal USA will increase the cosmetic giant's currently limited U.S. presence in direct-to-physician skin care product sales as well as continue to build the company's global portfolio of "dermocosmetics," L'Oreal said. Announced May 9, the transaction is expected to close in the next two months.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel